Literature DB >> 26562273

Therapies for actinic keratosis with a focus on cosmetic outcomes.

Julien Lanoue, Timothy Do, Gary Goldenberg1.   

Abstract

Actinic keratosis (AK) is a commonly encountered premalignant epidermal lesion that has a predilection to manifest on highly visible areas such as the face, head, and hands. Lesions may be cosmetically unappealing and have been reported to reduce patients' quality of life (QOL), but appropriate treatment can resolve these issues. In this article, we review the efficacy of the most commonly utilized treatments for AKs including topical medications, procedural modalities, and light-based therapies, and we discuss the relevant cosmetic considerations and outcomes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26562273

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  2 in total

1.  Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial.

Authors:  Brian Berman; Stephen Tyring; Walter K Nahm; Marie Louise Østerdal; Astrid H Petersen; Daniel M Siegel
Journal:  J Clin Aesthet Dermatol       Date:  2017-11-01

2.  A Prospective Pilot Clinical Trial to Evaluate the Efficacy and Safety of Topical Therapy with Ingenol Mebutate Gel 0.015% for Actinic Keratosis on an Expanded Area of the Chest.

Authors:  Douglas C Wu; Isabella Guiha; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2017-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.